OraPro oral vaccine technology
A new paradigm in distribution, administration and immunization
Vaccinations have changed the world and saved tens of millions of lives. But the methods for distributing and administering them have historically restricted their use worldwide. Injections must be given by healthcare professionals and most vaccines are still dependent on the ‘cold chain’ – constant refrigeration throughout the transit process from lab to patient. Any break in this chain will render the vaccine inactive.
Our proprietary thermally stable oral vaccine platform technology, OraPro, enables the provision of vaccines in a tablet, capsule or nasal spray. This ground-breaking technology successfully delivers non-replicating viral vector vaccines through the mucous membranes, creating effective immunity against infectious diseases. The OraPro approach can be applied to most respiratory, intestinal or systemic viruses.